Thursday, August 01, 2019 10:36:14 PM
Budget deal signed accounting for GSE costs in next fiscal year.[Check]
Trade talks on hold. Treasury can re-task to housing finance.[Check]
Tariff income will offset ending NWS.[Check]
En banc ready to be published.[Check]
Kudlow has the plan ready to release.[Check]
Tomorrow begins the final accumulation of another $20 million of commons for my sheets.
In 14 months everyone on my team will retire with new catamarans, vacation homes, and full financial security.
When I started this business over 25 years ago my dream was to take care of my people and to build a business that made a difference in the lives of those I cared about. I hired each one of them. They are family to me. This move will make or break our shop. This decision, my decision, will impact the lives of 82 families.
My name is Gary and I have run a private firm for the last two and a half decades. I traded in the open pits of the CME. I once lost over a million on a trade and I have made many times that since. I helped pioneer some of the software in Thomson Reuters Eikon. I ran the algorithm that put up the ask wall to accumulate large quantities of shares in FNMA since May. I am also the one who has been shorting FMCC at open periodically while remaining long on FNMA. We now begin our final buy orders of FMCC to even up for the trip past $10.00 per share.
As we move into the final leg of this journey there is no turning back. There is no stop loss set. We're fully committed to our long position in FMCC and FNMA commons. Our trust now rests in the hands of our judiciary and people like Calabria, Mnuchin, Trump, Kudlow and Larry Fink to keep their promises.
It may be that we all fail together. It may be that our analysis, hopes, and plans do not work. But I have a feeling...a feeling that those who stood tall against this 11 year storm will see the light of day and boundless profit will be theirs.
This shall be my last post. Goodluck everyone. All your dreams are about to come true.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM